Search bioRxiv⌕ Search

bioRxiv · 10.1101/2024.03.26.586792

Conservation and diversification of genes regulating brassinosteroid biosynthesis and signaling

Abstract

Brassinosteroids (BRs) are important regulators that control myriad aspects of plant growth and development including biotic and abiotic stress responses, such that modulating BR homeostasis and signaling presents enormous opportunities for plant breeding and crop improvement. Enzymes and proteins involved in the biosynthesis and signaling of BRs are well understood from molecular genetics and phenotypic analysis in Arabidopsis thaliana; however, knowledge of molecular function of these genes in other plant species, especially cereal crop plants, is highly limited. In this manuscript, we comprehensively review functional studies of BR genes in Arabidopsis, maize, rice, Setaria, Brachypodium, and soybean to identify conserved and diversified functions across plant species, and to highlight cases where additional research is in order. We performed phylogenetic analysis of gene families known to be involved in biosynthesis and signaling of BRs and re-analyzed publicly available transcriptomic data. Gene trees coupled to expression data provide a useful guide to supplement future research on BRs in these important crop species, such as to allow researchers to identify genes to target through gene editing techniques to perform BR-related functional studies.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Zebosi, B., Vollbrecht, E. B., Best, N. B.. 2024-04-02. Conservation and diversification of genes regulating brassinosteroid biosynthesis and signaling. https://doi.org/10.1101/2024.03.26.586792

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Sequencing of the Prnp-Prnd deletion junction in Prn-/- mouse tissues after formaldehyde fixation and >22 years at room temperature.

In 2004, Nicolas Genoud and colleagues reported that deletion of Prnd, which encodes Doppel, prevented neurodegeneration in mice with extensive Prnp deletions. The work tested the proposal that abnormal Doppel expression in the brain caused cerebellar degeneration in mice lacking the cellular prion protein, PrP. Advances in automated image analysis have expanded scrutiny of published figures, and post-publication reviews have raised concerns about apparent figure manipulation in this work, calling its authenticity and reliability into question. Here we assemble the surviving contemporaneous records of the original work and report new experiments on archived tissue. To reassess the reported genetic rearrangement, DNA from archived paraffin-embedded brain tissue was amplified across the putative deletion junction and analyzed by bidirectional Sanger sequencing and comparison with mouse reference sequences. The two reads spanned 607 positions and placed Prnp-side sequence, a 34-base loxP site and Prnd-side sequence in the expected order, with 93 intervening bases that matched bacteriophage P1 loxP-flanking and plasmid cloning-site sequences rather than the mouse reference and therefore probably derive from the targeting construct. Independent de novo reassembly from the 2025 Sanger chromatogram files reproduced the junction sequence; the assemblies differed only at three terminal bases with low base-call quality. These findings support the expected local junction arrangement and provide a publicly inspectable sequence description that extends the molecular information presented in the original paper. The amplicon size and the position of the loxP site match the values stated in the original paper, as does the approximately 18-kb distance between the two flanking sequences in the wild-type genome, which the deletion brings together. Recovery of junction DNA after more than two decades of room-temperature storage as paraformaldehyde-fixed, paraffin-embedded tissue demonstrates the value of retained material for reassessing historical experimental claims.

genetics↗

Language-Driven Clustering of Transfer, Persistence, Prevalence & Recovery Studies for Forensic Activity-Level Evaluation

Transfer, Persistence, Prevalence, and Recovery (TPPR) data are essential for forensic activity level evaluations (ALE); however, concerns remain regarding the accessibility of relevant literature. This study investigated whether automated literature retrieval and natural language processing (NLP) methods could be used to identify and characterize TPPR studies. Existing forensic repositories were combined with records retrieved through the Web of Science Application Programming Interface (API) and enriched with bibliographic metadata, producing a corpus of 3,279 unique records. Automated retrieval tools were evaluated, and transformer-based topic modeling was applied to examine the breadth of the literature. The results showed that database APIs provided the most reliable mechanism for literature retrieval, while topic modeling identified meaningful groupings corresponding to major forensic disciplines and trace evidence types. The findings indicate that TPPR literature exists and that automated methods can support its discovery and organization. Although the availability of literature does not necessarily imply suitability for ALE, the results suggest that the principal challenge is the discovery, assessment, and reuse of published studies rather than their absence. Automated retrieval, semantic search, and quality assessment frameworks may improve access to relevant evidence and support the development of forensic knowledge systems for evaluative reporting and Bayesian network construction.

genetics↗

Population-aware computational assessment of base-editing accessibility among pathogenic variants on human chromosome 21: an African-ancestry-focused pilot study

Background Population-aware gene-editing research requires independent evaluation of clinical variant evidence, ancestry-stratified allele observations, nucleotide correction chemistry, and sequence-level editing constraints. We developed a source-traceable chromosome 21 pilot connecting these dimensions without equating computational accessibility with therapeutic editability. Methods Reviewed ClinVar pathogenic/likely pathogenic single-nucleotide variants were matched by GRCh38 chromosome, position, REF and ALT to overall and African/African-American (AFR) gnomAD v4.1 exome allele counts. Exploratory frequency contrasts used two-sided Fisher exact tests and Benjamini-Hochberg correction. Higher-confidence variants with canonical adenine or cytosine base-editing chemistry underwent NGG PAM/editor-window screening, bystander enumeration, MANE v1.5 consequence annotation, theoretical joint-product assessment and chromosome 21-restricted guide-homology searches. Results Among 1,944 ClinVar variants, 851 matched gnomAD; 694 were quality-filtered and alternate-allele-observed overall, including 300 higher-confidence records. Six variants met exploratory AFR-elevation criteria. Of 234 higher-confidence ABE/CBE chemistry-compatible variants, 118 (50.4%) had at least one nominal NGG/PAM-window placement, 55 (23.5%) a nominal zero-bystander placement, and 44 (18.8%) a zero-bystander placement without an additional chromosome 21 NGG near-match within three mismatches. The 261 placements generated 295 hypothetical bystander events (195 distinct alleles); five distinct potential products overlapped pathogenic/likely pathogenic ClinVar alleles. Across placements, 764 theoretical target-corrected sequence states were enumerated, of which 503 contained at least one bystander. Three variant-level editing-accessibility comparisons between AFR-observed and AFR-unobserved alleles were not statistically significant (BH q=1.0). Conclusions Canonical correction chemistry substantially overestimates nominal local base-editor accessibility. A population-aware, transcript-informed computational framework can identify hypotheses for follow-up, but allele-frequency contrasts, guide-similarity results and enumerated sequence products do not establish clinical efficacy, experimental editing specificity or genome-wide off-target safety.

genetics↗